IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Pharma/fine chemicals roundup—30 April

9:46 AM MDT | April 30, 2013 | Deepti Ramesh

Lonza results in line with expectations Lonza, in its business update announcement for the first quarter of 2013, says that its business performance was solid and in line with expectations. “Earlier this year, we announced significant changes to our organization, aligning ourselves directly with markets we serve. The newly focused organization is taking hold while delivering on our first-quarter results,” says Richard Ridinger, CEO of Lonza. “At the same time, we are working broadly to assess the performance and efficiencies across of our...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa